Cargando…
Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who ar...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180339/ https://www.ncbi.nlm.nih.gov/pubmed/28053362 http://dx.doi.org/10.2471/BLT.16.169383 |
_version_ | 1782485513446359040 |
---|---|
author | Smit, G Suzanne A Apers, Ludwig Arrazola de Onate, Wouter Beutels, Philippe Dorny, Pierre Forier, An-Marie Janssens, Kristien Macq, Jean Mak, Ruud Schol, Sandrina Wildemeersch, Dirk Speybroeck, Niko Devleesschauwer, Brecht |
author_facet | Smit, G Suzanne A Apers, Ludwig Arrazola de Onate, Wouter Beutels, Philippe Dorny, Pierre Forier, An-Marie Janssens, Kristien Macq, Jean Mak, Ruud Schol, Sandrina Wildemeersch, Dirk Speybroeck, Niko Devleesschauwer, Brecht |
author_sort | Smit, G Suzanne A |
collection | PubMed |
description | OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who are seeking tuberculosis consultation at a centre for respiratory health care – and the associated costs per active case of tuberculosis identified between 2007 and 2014, we compared the cost–effectiveness of each component. The applied perspective was that of the Flemish government. FINDINGS: The three most cost-effective activities appeared to be the follow-up of asylum seekers who were found to have abnormal X-rays in initial screening at the Immigration Office, systematic screening in prisons and contact investigation. The mean costs of these activities were 5564 (95% uncertainty interval, UI: 3791–8160), 11 603 (95% UI: 9010–14 909) and 13 941 (95% UI: 10 723–18 201) euros (€) per detected active case, respectively. The periodic or supplementary initial screening of asylum seekers and the screening of new immigrants from high-incidence countries – which had corresponding costs of €51 813 (95% UI: 34 855–76 847), €126 236 (95% UI: 41 984–347 822) and €418 359 (95% UI: 74 975–1 686 588) – appeared much less cost-effective. Between 2007 and 2014, no active tuberculosis cases were detected during screening in the juvenile detention centres. CONCLUSION: In Flanders, tuberculosis screening in juvenile detention centres and among new immigrants and the periodic or supplementary initial screening of asylum seekers appear to be relatively expensive ways of detecting people with active tuberculosis. |
format | Online Article Text |
id | pubmed-5180339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | World Health Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-51803392017-01-05 Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium Smit, G Suzanne A Apers, Ludwig Arrazola de Onate, Wouter Beutels, Philippe Dorny, Pierre Forier, An-Marie Janssens, Kristien Macq, Jean Mak, Ruud Schol, Sandrina Wildemeersch, Dirk Speybroeck, Niko Devleesschauwer, Brecht Bull World Health Organ Research OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who are seeking tuberculosis consultation at a centre for respiratory health care – and the associated costs per active case of tuberculosis identified between 2007 and 2014, we compared the cost–effectiveness of each component. The applied perspective was that of the Flemish government. FINDINGS: The three most cost-effective activities appeared to be the follow-up of asylum seekers who were found to have abnormal X-rays in initial screening at the Immigration Office, systematic screening in prisons and contact investigation. The mean costs of these activities were 5564 (95% uncertainty interval, UI: 3791–8160), 11 603 (95% UI: 9010–14 909) and 13 941 (95% UI: 10 723–18 201) euros (€) per detected active case, respectively. The periodic or supplementary initial screening of asylum seekers and the screening of new immigrants from high-incidence countries – which had corresponding costs of €51 813 (95% UI: 34 855–76 847), €126 236 (95% UI: 41 984–347 822) and €418 359 (95% UI: 74 975–1 686 588) – appeared much less cost-effective. Between 2007 and 2014, no active tuberculosis cases were detected during screening in the juvenile detention centres. CONCLUSION: In Flanders, tuberculosis screening in juvenile detention centres and among new immigrants and the periodic or supplementary initial screening of asylum seekers appear to be relatively expensive ways of detecting people with active tuberculosis. World Health Organization 2017-01-01 2016-11-03 /pmc/articles/PMC5180339/ /pubmed/28053362 http://dx.doi.org/10.2471/BLT.16.169383 Text en (c) 2017 The authors; licensee World Health Organization. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. |
spellingShingle | Research Smit, G Suzanne A Apers, Ludwig Arrazola de Onate, Wouter Beutels, Philippe Dorny, Pierre Forier, An-Marie Janssens, Kristien Macq, Jean Mak, Ruud Schol, Sandrina Wildemeersch, Dirk Speybroeck, Niko Devleesschauwer, Brecht Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium |
title | Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium |
title_full | Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium |
title_fullStr | Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium |
title_full_unstemmed | Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium |
title_short | Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium |
title_sort | cost–effectiveness of screening for active cases of tuberculosis in flanders, belgium |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180339/ https://www.ncbi.nlm.nih.gov/pubmed/28053362 http://dx.doi.org/10.2471/BLT.16.169383 |
work_keys_str_mv | AT smitgsuzannea costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT apersludwig costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT arrazoladeonatewouter costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT beutelsphilippe costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT dornypierre costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT forieranmarie costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT janssenskristien costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT macqjean costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT makruud costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT scholsandrina costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT wildemeerschdirk costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT speybroeckniko costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium AT devleesschauwerbrecht costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium |